Plain-English translation of NCT06959511 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called to see if it can shrink advanced thyroid cancer before surgery. The goal is to give patients the medication for several weeks to shrink their tumors, which may make the upcoming surgery safer, less complicated, and more likely to remove all the cancer completely. Researchers want to understand how well this medication works and how safe it is for people with different types of thyroid cancer.
When thyroid cancer is advanced and has spread to nearby tissues or lymph nodes, surgery can be very risky and complicated. This medication is being tested to see if shrinking the tumor first can reduce surgical complications and help doctors remove all the cancer more completely.
You likely qualify if…
You likely don't qualify if…
You would take a daily pill (60 mg) for 4 weeks, with regular clinic visits to check on how well the medication is working and monitor for side effects through blood tests and imaging scans. After completing the medication cycle, you would undergo surgery to remove the thyroid cancer. Throughout the trial, you would also complete questionnaires about your quality of life and any symptoms you experience.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States